PATENT CLAIM ANALYSIS

Application Number: 16137324
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-07
Patent Classification: ["506", "009000"]

Abstract:
Provided herein are methods for determining a diagnosis and/or prognosis for prostate cancer using the ratio of FOXC1:FOXA1 in a sample obtained from a subject.

Claim (Index 62):
The method of  claim 61 , wherein the treatment plan comprises (a) discontinuing at least one anti-cancer therapy for a subject having a good prognosis, (b) maintaining at least one anti-cancer therapy for a subject having a good prognosis, (c) initiating at least one anti-cancer therapy for a subject having a good prognosis, (d) discontinuing at least one anti-cancer therapy for a subject having a poor prognosis, or (e) initiating at least one anti-cancer therapy for a subject having a poor prognosis.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 506.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15617333', '14909916', '15271988', '13483176', '13320283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5783104887587681
- 35 USC 102 Novelty (BERT): 0.5341410789749232
- Combined Prediction Score: 0.5738935477803837
- Mean Citation Score: 270.179616
- Max Citation Score: 342.38446
- Similarity Product: 165.08957138458848

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test